<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">METIPRANOLOL HYDROCHLORIDE</span><br/>(me-ti-pran'ol-ol)<br/><span class="topboxtradename">OptiPranolol<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">beta-adrenergic antagonist (sympatholytic)</span>; <span class="classification">eye preparation</span>; <span class="classification">mitotic (antiglaucoma agent)</span><br/><b>Prototype: </b>Propranolol<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.3% ophthalmic solution</p>
<p>
<b>See Appendix A-1.</b>
</p>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>